Why do i cry so much always? Im not normal. No one cries as much as me around me. I cry looking at people on road, I cry looking at underprivileged children playing in the sun with no proper food, shelter, clothing. I cry seeing an old man eating alone because it feels lonely like […]
Geoffrey Hinton has spent a lifetime teaching computers to learn. Now he worries that artificial brains are better than ours.
Why the Godfather of A.I. Fears What He’s Built Read More »
Guest blog: Teacher’s experiences help students navigate mental health MHA Admin Wed, 09/27/2023 – 08:10 September 27, 2023 by Michael Cullinane As a 46-year-old veteran high school teacher, I often worry my students will soon write me off with an “Okay, Boomer” response. Although a member of Generation X, technically I’m closer in age to
Guest blog: Teacher’s experiences help students navigate mental health Read More »
Mania does not bring people joy, it steals it.
Depression Is Not Sadness and Mania Is Not Happiness Read More »
A Personal Perspective: How can Adam Grant’s newest book help OCD sufferers? In more ways than you think.
Tapping the Hidden Potential Inside OCD Read More »
The results of this study suggest that the fear of missing out (FoMO) undermines inhibitory control by consuming more cognitive resources in the early conflict detection stage and leading to insufficient cognitive resources in the later stages of the inhibitory process. These findings suggest that FoMO can undermine inhibitory control in the social media context.
Music Performance Anxiety (MPA) is one of the most widespread and debilitating challenges facing musicians, affecting significant numbers of performers in terms of both their personal and professional functioning. Although numerous interventions exist to target MPA, its prevalence remains unchanged since the first large-scale studies of the 1980s, indicating that available interventions are having limited impact. This review synthesizes and critiques existing literature in order to investigate possible reasons for the limited efficacy of current approaches to managing MPA. Key concepts discussed include conceptual and methodological challenges surrounding defining MPA, theoretical perspectives on MPA’s etiology and manifestation, and the coping strategies and interventions used to manage MPA. MPA has predominantly been investigated pathologically and defined as a negative construct manifesting in unwanted symptoms. Based on this conceptualization, interventions largely seek to manage MPA through ameliorating symptoms. This review discusses possible reasons why this approach has broadly not proved successful, including the issue of relaxation being both unrealistic and counterproductive for peak performance, issues associated with intentionally changing one’s state creating resistance thus exacerbating anxiety, and focusing on the presence of, rather than response to, symptoms. Despite 50 years of research, MPA remains an unsolved enigma and continues to adversely impact musicians both on and off the stage. Reconceptualizing MPA as a normal and adaptive response to the pressures of performance may offer a new perspective on it, in terms of its definition, assessment and management, with practical as well as theoretical implications.
It’s not a virus! Reconceptualizing and de-pathologizing music performance anxiety Read More »
BackgroundIndividuals with depression have an increased dementia risk, which might be due to modifiable risk factors for dementia. This study investigated the extent to which the increased risk for dementia in depression is explained by modifiable dementia risk factors.MethodsWe used data from the English Longitudinal Study of Ageing (2008–2009 to 2018–2019), a prospective cohort study. A total of 7460 individuals were included [mean(standard deviation) age, 65.7 ± 9.4 years; 3915(54.7%) were women]. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale-8 (score ≥3) or self-reported doctor’s diagnosis. Ten modifiable risk factors for dementia were combined in the ‘LIfestyle for BRAin health’ (LIBRA) score. Dementia was determined by physician diagnosis, self-reported Alzheimer’s disease or the shortened version of the Informant Questionnaire on Cognitive Decline in the Elderly (average score ≥3.38). Structural equation modelling was used to test mediation of LIBRA score.ResultsDuring 61 311 person-years, 306 individuals (4.1%) developed dementia. Participants aged 50–70 years with depressive symptoms had higher LIBRA scores [difference(s.e.) = 1.15(0.10)] and a 3.59 times increased dementia risk [HR(95% CI) = 3.59(2.20–5.84)], adjusted for age, sex, education, wealth and clustering at the household level. In total, 10.4% of the dementia risk was mediated by differences in LIBRA score [indirect effect: HR = 1.14(1.03–1.26)], while 89.6% was attributed to a direct effect of depressive symptoms on dementia risk [direct effect: HR = 3.14(2.20–5.84)].ConclusionsModifiable dementia risk factors can be important targets for the prevention of dementia in individuals with depressive symptoms during midlife. Yet, effect sizes are small and other aetiological pathways likely exist.
Contributions of modifiable risk factors to increased dementia risk in depression Read More »
BackgroundIn the past 10 years an increasing number of randomised trials have examined the effects of transdiagnostic treatments of patients with depression or anxiety. We conducted the first comprehensive meta-analysis of the outcomes of this emerging field.MethodsWe used the searches in PubMed, PsychINFO, Embase and the Cochrane library of an existing database of randomised trials of psychological interventions for depression to identify studies comparing a transdiagnostic treatment of patients with depression or anxiety with a control group (deadline 1 January 2022). We conducted random-effects meta-analyses and examined the effects on depression and anxiety at the short and longer term.ResultsWe included 45 randomised controlled trials with 51 comparisons between a psychotherapy and a control group and 5530 participants. Thirty-five (78%) studies were conducted in the last 10 years. The overall effect size was g = 0.54 (95% CI 0.40–0.69; NNT = 5.87), with high heterogeneity (I2 = 78; 95% CI 71–83), and a broad PI (−0.31–1.39). The effects remained significant in a series of sensitivity analyses, including exclusion of outliers, adjustment for publication bias, for studies with low risk of bias, and in multilevel analyses. The results were comparable for depression and anxiety separately. At 6 months after randomisation the main effects were still significant, but not at 12 months, although the number of studies was small.ConclusionsTransdiagnostic treatments of patients with depression or anxiety are increasingly examined and are probably effective at the short term.
Transdiagnostic treatment of depression and anxiety: a meta-analysis Read More »
